Cargando…

Prostacyclin and PPARα Agonists Control Vascular Smooth Muscle Cell Apoptosis and Phenotypic Switch through Distinct 14-3-3 Isoforms

We hypothesized that prostacyclin (PGI(2)) protects vascular smooth muscle cell (VSMC) against apoptosis and phenotypic switch through peroxisome proliferator-activated receptor-α (PPARα) activation and 14-3-3 upregulation. Here we showed that transfection of rat aortic VSMC, A-10, with PGI(2)-produ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yen-Chung, Chu, Ling-Yun, Yang, Shu-Fan, Chen, Hua-Ling, Yet, Shaw-Fang, Wu, Kenneth K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701049/ https://www.ncbi.nlm.nih.gov/pubmed/23844263 http://dx.doi.org/10.1371/journal.pone.0069702

Ejemplares similares

PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists
por: Silswal, Neerupma, et al.
Publicado: (2012)

IP receptor-dependent activation of PPARγ by stable prostacyclin analogues
por: Falcetti, Emilia, et al.
Publicado: (2007)

Divergent signaling pathways cooperatively regulate TGFβ induction of cysteine-rich protein 2 in vascular smooth muscle cells
por: Wu, Meng-Ling, et al.
Publicado: (2014)

Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag
por: Kaufmann, Priska, et al.
Publicado: (2015)

Anti-inflammatory mechanisms of the vascular smooth muscle PPARγ
por: Mukohda, Masashi, et al.
Publicado: (2021)

Synthetic Prostacyclin Agonist Attenuates Pressure-Overloaded Cardiac Fibrosis by Inhibiting FMT
por: Masada, Kenta, et al.
Publicado: (2020)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

Binding of the Human 14-3-3 Isoforms to Distinct Sites in the Leucine-Rich Repeat Kinase 2
por: Manschwetus, Jascha T., et al.
Publicado: (2020)

MicroRNA-223-3p inhibits vascular calcification and the osteogenic switch of vascular smooth muscle cells
por: Han, Yingchun, et al.
Publicado: (2021)

PPARδ Agonist GW501516 Inhibits PDGF-Stimulated Pulmonary Arterial Smooth Muscle Cell Function Related to Pathological Vascular Remodeling
por: Liu, Guangjie, et al.
Publicado: (2013)

PROSTACYCLIN IN HEALTH AND DISEASE
Publicado: (1983)

Prostacyclin: An Inflammatory Paradox
por: Stitham, Jeremiah, et al.
Publicado: (2011)

Vascular Smooth Muscle Cells Phenotypic Switching in Cardiovascular Diseases
por: Tang, Hao-Yue, et al.
Publicado: (2022)

Methyltransferase‐like 3 suppresses phenotypic switching of vascular smooth muscle cells by activating autophagosome formation
por: Fang, Ze‐Min, et al.
Publicado: (2022)

Safety of PPAR Agonists
por: Home, Philip
Publicado: (2011)

Prostacyclin Synthesis and Prostacyclin Receptor Expression in the Porcine Myometrium: Prostacyclin Potential to Regulate Fatty Acid Transporters, Cytokines and Contractility-Related Factors
por: Blitek, Agnieszka, et al.
Publicado: (2022)

Panax notoginseng Saponins Attenuate Phenotype Switching of Vascular Smooth Muscle Cells Induced by Notch3 Silencing
por: Liu, Nan, et al.
Publicado: (2015)

NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis
por: Burger, Fabienne, et al.
Publicado: (2021)

Muscle Injuries Induce a Prostacyclin‐PPARγ/PGC1a‐FAO Spike That Boosts Regeneration
por: Luo, Lanfang, et al.
Publicado: (2023)

Enhanced Pulmonary Vascular and Alveolar Development via Prenatal Administration of a Slow-Release Synthetic Prostacyclin Agonist in Rat Fetal Lung Hypoplasia
por: Umeda, Satoshi, et al.
Publicado: (2016)

Pervasive 3′-UTR Isoform Switches During Mouse Oocyte Maturation
por: He, Yuanlin, et al.
Publicado: (2021)

KLF4-PFKFB3-driven glycolysis is essential for phenotypic switching of vascular smooth muscle cells
por: Zhang, Xinhua, et al.
Publicado: (2022)

Crosstalk between BMP signaling and KCNK3 in phenotypic switching of pulmonary vascular smooth muscle cells
por: Yeo, Yeongju, et al.
Publicado: (2022)

How vascular smooth muscle cell phenotype switching contributes to vascular disease
por: Cao, Genmao, et al.
Publicado: (2022)

Use of prostacyclin in pulmonary hypertension
por: Vicente, R, et al.
Publicado: (1998)

Role of prostacyclin in pulmonary hypertension
por: Mitchell, Jane A., et al.
Publicado: (2014)

Prostacyclin Regulation of Allergic Inflammation
por: Patel, Kunj, et al.
Publicado: (2022)

First-in-child use of the oral selective prostacyclin IP receptor agonist selexipag in pulmonary arterial hypertension
por: Geerdink, Lianne M., et al.
Publicado: (2017)

Administration of Slow-Release Synthetic Prostacyclin Agonist Promoted Angiogenesis and Skeletal Muscle Regeneration for Limb Ischemia
por: Nakagawa, Takaya, et al.
Publicado: (2020)

Targeting smooth muscle cell phenotypic switching in vascular disease
por: Chakraborty, Raja, et al.
Publicado: (2021)

Role of Vascular Smooth Muscle Cell Phenotype Switching in Arteriogenesis
por: Ashraf, Jasni Viralippurath, et al.
Publicado: (2021)

Vascular smooth muscle cell phenotype switching in carotid atherosclerosis
por: Chou, Elizabeth L., et al.
Publicado: (2021)

Pseudoginsenoside F11, a Novel Partial PPARγ Agonist, Promotes Adiponectin Oligomerization and Secretion in 3T3-L1 Adipocytes
por: Wu, Guoyu, et al.
Publicado: (2013)

Expression of Nik-related kinase in smooth muscle cells attenuates vascular inflammation and intimal hyperplasia
por: Lu, Yi-Jhu, et al.
Publicado: (2020)

Design, sythesis and evaluation of a series of 3- or 4-alkoxy substituted phenoxy derivatives as PPARs agonists
por: Zhang, Jun, et al.
Publicado: (2017)

Hierarchized phosphotarget binding by the seven human 14-3-3 isoforms
por: Gogl, Gergo, et al.
Publicado: (2021)

Serotonin 2B Receptor (5-HT(2B) R) Signals through Prostacyclin and PPAR-ß/δ in Osteoblasts
por: Chabbi-Achengli, Yasmine, et al.
Publicado: (2013)

In Utero Exposure to Maternal Diabetes Impairs Vascular Expression of Prostacyclin Receptor in Rat Offspring
por: Van Huyen, Jean-Paul Duong, et al.
Publicado: (2010)

Agonist-dependent internalization and trafficking of the human prostacyclin receptor: A direct role for Rab5a GTPase
por: O'Keeffe, Martina B., et al.
Publicado: (2008)

A thorough QT study in the context of an uptitration regimen with selexipag, a selective oral prostacyclin receptor agonist
por: Hoch, Matthias, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jdf2i0v204t9p6gqm8jdcr2oi7